Year: 2023
Type: article
Study design: Observational Study
Abstract: Background Patients with Type 2 diabetes mellitus (T2D) are at risk for micro- and macrovascular complications. Implementable risk scores are needed to improve targeted prevention for patients that are particularly susceptible to complications. The epigenetic clock estimates an individual’s biological age using DNA methylation profiles. Methods In this study, we examined older adults of the Berlin Aging Study II that were reexamined on average 7.4 years after baseline assessment as part of the GendAge study. DNA methylation age (DNAmA) and its deviation from chronological age DNAmA acceleration (DNAmAA) were calculated with the 7-CpG clock (available at both timepoints, n = 1,071), Horvath’s clock, Hannum’s clock, PhenoAge and GrimAge (available at follow-up only, n = 1,067). T2D associated complications were assessed with the Diabetes Complications Severity Index (DCSI). Results We report on a statistically significant association between oral glucose tolerance test results and Hannum and PhenoAge DNAmAA. PhenoAge was also associated with fasting glucose. In contrast, we found no cross-sectional association after covariate adjustment between DNAmAA and a diagnosis of T2D. However, longitudinal analyses showed that every additional year of 7-CpG DNAmAA at baseline increased the odds for developing one or more additional complications or worsening of an already existing complication during the follow-up period by 11% in male participants with T2D. This association persisted after covariate adjustment (OR = 1.11, p = 0.045, n = 56). Conclusion Although our results remain to be independently validated, this study shows promising evidence of utility of the 7-CpG clock in identifying patients with diabetes who are at high risk for developing complications.
Source: Communications Medicine
Institutions: Humboldt-Universität zu Berlin, Charité – Universitätsmedizin Berlin, University of Lübeck, University of Zurich, University Hospital Zurich, Freie Universität Berlin, University of Oslo, Berlin-Brandenburger Centrum für Regenerative Therapien, Berlin Institute of Health at Charité - Universitätsmedizin Berlin
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,573
Awards: G125589385, Verbundprojekt: Berliner Altersstudie II - BASE II - , Teilvorhaben: Projektkoordination, Datenbank und Psychologie, GendAge - Geschlechts-sensitive Vorbeugung kardiovaskulärer und metabolischer Krankheiten bei älteren Erwachsenen in Deutschland - Teilprojekt 2 (GendAge-HU), Verbundprojekt: Berliner Altersstudie II - BASE II - , Teilvorhaben: Survey Methodik und Sozialwissenschaft, G4339657903, G4580474731, Verbundprojekt: Berliner Altersstudie II - BASE II - , Teilvorhaben: Innere Medizin/Geriatrie, GendAge - Geschlechts-sensitive Vorbeugung kardiovaskulärer und metabolischer Krankheiten bei älteren Erwachsenen in Deutschland - Teilprojekt 1 und Verbundkoordination (GendAge-Charité), Verbundprojekt: Berliner Altersstudie II - BASE II - , Teilvorhaben: Molekulargenetik, Die Berliner Altersstudie (BASE): Fortführung und Erweiterung (BASE II)
OpenAlex ID: W4319943898
